Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of Kartogenin (KGN) to preparation of drugs for improving osteogenic differentiation capability of bone marrow mesenchymal stem cells (BM-MSCs)

A technology of bone marrow mesenchymal and osteogenic differentiation, applied in the field of cell medicine, can solve the problem of no related reports on KGN osteogenic induction, and achieve the effect of delaying the process of osteoporosis, promoting osteogenic differentiation and promoting bone healing.

Inactive Publication Date: 2018-11-09
THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Kartogenin (KGN) was discovered by Kristen Johnson et al. in 2012 and found that it can induce cartilage formation by regulating the CBFb-RUNX1 transcriptional program, but there is no relevant report on KGN in terms of osteogenesis induction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of Kartogenin (KGN) to preparation of drugs for improving osteogenic differentiation capability of bone marrow mesenchymal stem cells (BM-MSCs)
  • Application of Kartogenin (KGN) to preparation of drugs for improving osteogenic differentiation capability of bone marrow mesenchymal stem cells (BM-MSCs)
  • Application of Kartogenin (KGN) to preparation of drugs for improving osteogenic differentiation capability of bone marrow mesenchymal stem cells (BM-MSCs)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] (1) Resuscitated bone marrow mesenchymal stem cells, inoculated at 175cm 2 Add 20 mL of complete medium to the culture flask, place at 37°C, 5% CO 2 Incubate in the incubator and change the medium every three days. Cells in the logarithmic growth phase were inoculated in multiple 12-well culture plates, complete medium was added, and the medium was changed every three days. After the cell density was greater than 90%, they were divided into groups, and osteogenic induction medium was added. At the same time, complete medium (CTRL group), 0.005% DMSO, 10nM KGN, 100nM KGN, and 1000nM KGN were added, and the medium was changed every three days. Alizarin red staining and quantification of calcium nodules were performed 14 days later.

Embodiment 2

[0035] (1) Resuscitated bone marrow mesenchymal stem cells, inoculated at 175cm 2 Add 20 mL of complete medium to the culture flask, place at 37°C, 5% CO 2 Incubate in the incubator and change the medium every three days. Cells in the logarithmic growth phase were inoculated in multiple 12-well culture plates, complete medium was added, and the medium was changed every three days. After the cell density was greater than 90%, they were divided into groups, and osteogenic induction medium was added. At the same time, complete medium (CTRL group), 0.005% DMSO, 10nM KGN, 100nM KGN, and 1000nM KGN were added, and the medium was changed every three days. After 14 days, the expression of osteogenesis-related genes and proteins was detected.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses the application of KGN to preparation of drugs for improving the osteogenic differentiation capability of BM-MSCs, belonging to the field of cell medicine. Experimental resultsshow that KGN can promote the osteogenic differentiation of BM-MSC and improve the gene expression levels of SIRT1, ALP, COL1A1, RUNX2 and BGLAP and the expression contents of corresponding proteins.Therefore, the application of invention proves that KGN can promote the osteogenic differentiation potential of stem cells. The application KGN to preparation of drugs for improving the osteogenic differentiation capability of BM-MSCs in the invention can provide a brand-new bone-healing-capability-promoting scheme for medical research, tissue engineering research and the like.

Description

technical field [0001] The invention belongs to the field of cell medicine, and relates to the application of Kartogenin (hereinafter referred to as KGN) in the preparation of drugs for improving the osteogenic differentiation ability of bone marrow mesenchymal stem cells. Background technique [0002] Bone marrow mesenchymal stem cells (BM-MSCs) are a type of adult stem cells that reside in the bone marrow together with hematopoietic stem cells. Adult tissue-derived BM-MSCs are highly attractive in biological tissue engineering due to their self-renewal, high proliferation, and mesoderm differentiation potential, which can repair damaged tissues and promote tissue functional restoration in clinical practice. Today's academic circles generally believe that osteoblasts originate from BM-MSCs. Improving the osteogenic differentiation ability of BM-MSC has guiding significance for bone biology research and even clinical treatment. [0003] SIRT1 gene is a multifunctional tran...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/192A61P19/08A61P19/10
CPCA61K31/192A61P19/08A61P19/10
Inventor 王一帆何帆陈曦闫金库李茂陈广东张文朱彩虹刘滔杨惠林
Owner THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com